Abstract
Preventing infection at the pathogen portal of entry through induction of mucosal immunity is an exciting prospect. Mucosal vaccines administered either orally or nasally are effective in inducing antigen-specific immune responses in both the systemic and the mucosal compartment. However, the mucosal antigen-specific immune response is weak, because most protein antigens applied mucosally can evoke only a weak immune response. One strategy to overcome the weakness of the immune response is the co-administration of mucosal adjuvant with the vaccine antigen. Unfortunately, the development of a safe and effective mucosal adjuvant has proved challenging. Cytokines are promising adjuvants because they are safe, human-derived materials and display potent immune-modulating functions. Members of the tumor necrosis factor (TNF)/TNF receptor (TNFR) superfamily are critically involved in maintaining homeostasis of the immune system. We determined the potential of TNF superfamily cytokines as mucosal adjuvants for induction of mucosal immune responses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ada G (2001) Vaccines and vaccination. N Engl J Med 345:1042–1053
Brandtzaeg P (2007) Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25:5467–5484
Eriksson K, Holmgren J (2002) Recent advances in mucosal vaccines and adjuvants. Curr Opin Immunol 14:666–672
Gorbach SL, Khurana CM (1971) Toxigenic Escherichia coli in infantile diarrhea in Chicago. J Lab Clin Med 78:981–982
Hehlgans T, Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115:1–20
Holmgren J, Czerkinsky C (2005) Mucosal immunity and vaccines. Nat Med 11:S45–S53
Kayamuro H, Abe Y, Yoshioka Y et al (2009a) The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses. Biomaterials 30:5869–5876
Kayamuro H, Yoshioka Y, Abe Y et al (2009b) TNF superfamily member, TL1A, is a potential mucosal vaccine adjuvant. Biochem Biophys Res Commun 384:296–300
Mutsch M, Zhou W, Rhodes P et al (2004) Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med 350:896–903
Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148–158
Shibata H, Yoshioka Y, Ikemizu S et al (2004) Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window. Clin Cancer Res 10:8293–8300
Tamada K, Chen L (2006) Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules. Cancer Immunol. Immunother 55:355–362
Acknowledgments
This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and from the Japan Society for the Promotion of Science (JSPS). The study was also supported in part by Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan; by Health Sciences Research Grants for Research on Publicly Essential Drugs and Medical Devices, from the Japan Health Sciences Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this paper
Cite this paper
Kayamuro, H. et al. (2011). Identification of New Candidates as Mucosal Vaccine Adjuvant in TNF Family Cytokines. In: Wallach, D., Kovalenko, A., Feldmann, M. (eds) Advances in TNF Family Research. Advances in Experimental Medicine and Biology, vol 691. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6612-4_31
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6612-4_31
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6611-7
Online ISBN: 978-1-4419-6612-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)